Related Experiment Video
Updated: Jan 9, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Individualised Treatment Effects Estimation with Composite Treatments and Composite Outcomes
None:
Estimating individualised treatment effect (ITE) - that is the causal effect of a set of variables (also called exposures, treatments, actions, policies, or interventions), referred to as composite treatments, on a set of outcome variables of interest, referred to as composite outcomes, for a unit from observational data - remains a fundamental problem in causal inference with applications across disciplines, such as healthcare, economics, education, social science, marketing, and computer science. Previous work in causal machine learning for ITE estimation is limited to simple settings, like single treatments and single outcomes. This hinders their use in complex real-world scenarios; for example, consider studying the effect of different ICU interventions, such as beta-blockers and statins for a patient admitted for heart surgery, on different outcomes of interest such as atrial fibrillation and in-hospital mortality. The limited research into composite treatments and outcomes is primarily due to data scarcity for all treatments and outcomes. To address the above challenges, we propose a novel and innovative hypernetwork-based approach, called H-Learner, to solve ITE estimation under composite treatments and composite outcomes, which tackles the data scarcity issue by dynamically sharing information across treatments and outcomes. Our empirical analysis with binary and arbitrary composite treatments and outcomes demonstrates the effectiveness of the proposed approach compared to existing methods.Clinical Relevance-This paper develops a novel methodology, the H-Learner, to estimate individualised treatment effects when clinicians need to consider multiple interventions simultaneously to impact several patient outcomes. By accurately estimating these complex, individualised effects from observational data, this method has the potential to provide clinicians with more precise insights for tailoring treatment strategies, ultimately leading to improved patient care and outcomes in complex clinical scenarios where single interventions and outcomes are insufficient to capture the full picture.
Related Concept Videos
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Comparing the Survival Analysis of Two or More Groups
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mechanistic Models: Compartment Models in Individual and Population Analysis

